EUVIMEDEUVIMED entdecken
Open Access

A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index

Muhammed Recai Akdogan, Meltem Alkan Melikoglu

Northern Clinics of Istanbul · 2024 · 115-119

DOI: 10.14744/nci.2023.90132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Northern Clinics of Istanbul, 2024. Verfasst von Muhammed Recai Akdogan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Ataturk University Faculty of Medicine, Erzurum, Turkiye. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Biomarkers using routine laboratory tests accurately presenting systemic lupus erythematosus (SLE) disease activity may have important practical values in clinical settings. The primary purpose of this study was to investigate neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII; neutrophil X platelet/lymphocyte) as potential biomarkers of disease activity in cases with SLE. METHODS: In this case-control observational study, cases with SLE and demographically similar healthy controls were included. For clinical evaluation demographic features, disease duration and drugs were recorded. SLE clinical disease activity was assessed with SLEDAI scores. For laboratory assessments; erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and C3-C4 levels and anti-dsDNA positivity were recorded. Based on the simultaneous complete blood count (CBC) of the participants NLR, PLR and SII were calculated. The correlation between clinical and laboratory data was analyzed. RESULTS: 68 cases with SLE (64 women, 8 men) and 69 controls (65 women, 4 men) were included in this investigation. The demographic features of the cases and controls were similar. ESR, CRP, NLR, PLR and SII scores were statistically higher in cases with SLE than controls (p

Schlagwörter

Stichwörter der Autor:innen

Biomarkerdisease activityneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratiosystemic immune-inflammation indexsystemic lupus erythematosus

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Ataturk University Faculty of Medicine, Erzurum, Turkiye.
  • Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Ataturk University Faculty of Medicine, Erzurum, Turkiye.

Zitieren

APA

Akdogan, M. R., & Melikoglu, M. A. (2024). A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index. Northern Clinics of Istanbul, 115-119. https://doi.org/10.14744/nci.2023.90132

Vancouver

Akdogan MR, Melikoglu MA. A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index. Northern Clinics of Istanbul. 2024:115-119. doi:10.14744/nci.2023.90132

BibTeX
@article{Akdogan2024,
  author = {Akdogan, Muhammed Recai and Melikoglu, Meltem Alkan},
  title = {A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index},
  journal = {Northern Clinics of Istanbul},
  year = {2024},
  pages = {115--119},
  doi = {10.14744/nci.2023.90132}
}
Kostenlos starten →